What is the appropriate dose of ferrous sulfate for a 4‑year‑old child weighing 17 kg with a hemoglobin level of 8.6 g/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Oral Ferrous Sulfate Dosing for Pediatric Iron Deficiency Anemia

For this 4-year-old child (17 kg) with hemoglobin of 8.6 g/dL, prescribe ferrous sulfate at 3 mg/kg/day of elemental iron once daily, which equals approximately 51 mg of elemental iron per day (or one 324 mg ferrous sulfate tablet containing 65 mg elemental iron once daily). 1

Dosing Algorithm

The standard approach for treating iron deficiency anemia in children is:

  • Dose: 3 mg/kg/day of elemental iron once daily 1
  • For this patient: 17 kg × 3 mg/kg = 51 mg elemental iron daily
  • Practical formulation: One ferrous sulfate 324 mg tablet (containing 65 mg elemental iron) once daily 2

This low-dose, once-daily regimen is supported by the highest quality pediatric evidence showing superior efficacy compared to alternative iron formulations while maintaining excellent tolerability 1.

Evidence Supporting This Recommendation

The 2017 JAMA randomized clinical trial directly compared 3 mg/kg once-daily ferrous sulfate versus iron polysaccharide complex in children aged 9-48 months with nutritional IDA 1. Ferrous sulfate demonstrated significantly greater hemoglobin increase (mean 4.0 g/dL vs 3.4 g/dL over 12 weeks, difference 1.0 g/dL, p<0.001) and higher rates of complete IDA resolution (29% vs 6%, p=0.04). This once-daily, low-dose approach contradicts older high-dose regimens (historically 6 mg/kg/day in divided doses) but provides better real-world outcomes.

Additional supporting evidence from a 2020 study using 2 mg/kg/day ferrous sulfate in children aged 6-53 months showed 95% achieved hemoglobin normalization at 3 months with minimal adverse effects (only 4.8% drug-related events) 3. A 2026 multicenter trial further confirmed ferrous sulfate's efficacy, showing mean hemoglobin increases of 1.25 g/dL over 12 weeks 4.

Administration Details

  • Timing: Give on an empty stomach (fasting state) for optimal absorption 5
  • Form: Do not crush or chew tablets 2
  • Duration: Treat for 3 months minimum 3
  • Avoid: Tea and coffee within 1 hour of dosing (powerful absorption inhibitors) 6

Expected Response & Monitoring

Hemoglobin should increase by approximately 1 g/dL within 2 weeks of starting therapy 6. For this child with Hgb 8.6 g/dL:

  • Expected Hgb at 2 weeks: ~9.6 g/dL
  • Expected Hgb at 12 weeks: ~11.9-12.0 g/dL 3, 1

If hemoglobin fails to increase appropriately within 2 weeks, or ferritin does not improve within 1 month, consider switching to intravenous iron 6.

Safety Profile

The once-daily, 3 mg/kg ferrous sulfate regimen has excellent tolerability. A 1985 study of 278 one-year-old infants found no significant difference in vomiting, diarrhea, or fussiness between ferrous sulfate and placebo (6% vs 9%, p>0.50) 5. The 2017 JAMA trial actually reported more diarrhea with iron polysaccharide complex than ferrous sulfate (58% vs 35%, p=0.04) 1.

Parents should expect dark stools (not an adverse effect, but a marker of compliance) 5.

Common Pitfalls to Avoid

  1. Avoid divided dosing: Once-daily dosing improves compliance and efficacy compared to traditional three-times-daily regimens 1
  2. Avoid excessive dosing: Higher doses (>3 mg/kg/day) do not improve outcomes and increase side effects
  3. Avoid premature IV iron: Oral therapy should be tried first unless there are specific contraindications (malabsorption, inflammatory bowel disease, ongoing blood loss exceeding oral replacement capacity) 6
  4. Avoid stopping too early: Continue for full 3 months even after hemoglobin normalizes to replete iron stores 3

When to Consider IV Iron

Switch to intravenous iron if 6:

  • Hemoglobin fails to increase by 1 g/dL within 2 weeks despite confirmed adherence
  • Ferritin does not increase within 1 month
  • Documented malabsorption (post-bariatric surgery, active IBD)
  • Intolerable oral side effects despite dose adjustment

For IV iron in children, iron sucrose is preferred (most studied, FDA-approved from age 2 years in the US) at doses of 0.5-2 mg/kg, maximum 300 mg per infusion 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.